Recent 13F filings as of September 2025 show that 114 institutional investors hold a position in Astria Therapeutics, Inc. (NASDAQ:ATXS).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 30 Sep, 2025 | 6,485,420 | 0 | 0.00% | $47,213,857.00 |
| FMR LLC | 30 Sep, 2025 | 5,153,914 | -1,304,887 | -20.20% | $37,520,495.00 |
| Vestal Point Capital, LP | 30 Sep, 2025 | 4,956,000 | 434,000 | 9.60% | $36,079,680.00 |
| FCPM III SERVICES B.V. | 30 Sep, 2025 | 4,107,537 | 0 | 0.00% | $29,902,869.00 |
| Fairmount Funds Management LLC | 30 Sep, 2025 | 3,554,129 | 0 | 0.00% | $25,874,059.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 3,488,202 | -210,554 | -5.69% | $25,394,111.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 3,034,527 | 64,800 | 2.18% | $22,091,357.00 |
| TCG Crossover Management, LLC | 30 Sep, 2025 | 2,761,861 | 0 | 0.00% | $20,106,348.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 2,642,170 | 117,510 | 4.65% | $19,234,997.00 |
| VR Adviser, LLC | 30 Sep, 2025 | 2,457,348 | 0 | 0.00% | $17,889,493.00 |
| JPMORGAN CHASE & CO | 30 Sep, 2025 | 1,680,607 | -15,464 | -0.91% | $12,234,819.00 |
| Vivo Capital, LLC | 30 Sep, 2025 | 1,552,685 | 0 | 0.00% | $11,303,547.00 |
| Rosalind Advisors, Inc. | 30 Sep, 2025 | 1,542,520 | 413,812 | 36.66% | $1,112,773.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 1,433,769 | 14,436 | 1.02% | $10,437,838.00 |
| Nantahala Capital Management, LLC | 30 Sep, 2025 | 1,069,530 | 0 | 0.00% | $7,786,178.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 958,244 | -5,694 | -0.59% | $6,977,524.00 |
| STATE STREET CORP | 30 Sep, 2025 | 890,670 | -43,450 | -4.65% | $6,484,078.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 864,405 | 338,853 | 64.48% | $6,292,869.00 |
| CITADEL ADVISORS LLC | 30 Sep, 2025 | 848,982 | -521,641 | -38.06% | $6,180,589.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 30 Sep, 2025 | 834,000 | -41,000 | -4.69% | $6,071,520.00 |